Vasiliou V, Marselos M
Department of Pharmacology, Medical School, University of Ioannina, Greece.
Arch Toxicol. 1989;63(3):221-5. doi: 10.1007/BF00316372.
A hepatic soluble aldehyde dehydrogenase (ALDH), inducible by polycyclic aromatic hydrocarbons, was studied in Wistar rats in connection with substances known to affect drug metabolism or aldehyde dehydrogenase activity, such as phenobarbital (PB), disulfiram (DS), beta-diethylaminoethyl diphenylpropylacetate (SKF 525A) and calcium cyanamide (CC). 3-Methylcholanthrene (MC) was given as a model inducer of ALDH (100 mg/kg, i.p., as a single dose) and the animals were killed after 3 days. Pretreatment with PB (1 g/l drinking water, for 2 weeks) enhanced the inducing effect of MC. On the contrary, pretreatment with DS (100 mg/kg, i.p., daily x 4) reduced by 70% the expected increase in ALDH activity. Neither SKF 525A (25 mg/kg, i.p., daily x 4), nor CC (5 mg/kg, i.p., daily x 4) could affect the action of the inducer. At the above doses, basal ALDH activity was inhibited by DS (30%) and CC (70%), but was not affected at all by PB or SKF 525A. The results were somewhat different when the various effectors tested were administered to animals already treated with MC (20 mg/kg, i.p., daily x 6). In this case, DS did not affect the already induced ALDH activity. On the contrary, CC was still an effective inhibitor. Unexpectedly, post-treatment with SKF 525A further enhanced the initial induction brought about by MC. Our findings show that substances affecting microsomal drug metabolism can interfere with the process of ALDH induction by MC. The additive result of PB pretreatment is probably due to the enhanced accumulation of an active metabolite of MC.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了一种可被多环芳烃诱导的肝脏可溶性醛脱氢酶(ALDH),该研究在Wistar大鼠中进行,涉及已知会影响药物代谢或醛脱氢酶活性的物质,如苯巴比妥(PB)、双硫仑(DS)、β - 二乙氨基乙基二苯基丙酯(SKF 525A)和氰胺化钙(CC)。给予3 - 甲基胆蒽(MC)作为ALDH的模型诱导剂(100 mg/kg,腹腔注射,单次剂量),3天后处死动物。用PB(1 g/l饮用水,持续2周)预处理增强了MC的诱导作用。相反,用DS(100 mg/kg,腹腔注射,每日×4)预处理使ALDH活性预期增加降低了70%。SKF 525A(25 mg/kg,腹腔注射,每日×4)和CC(5 mg/kg,腹腔注射,每日×4)均不能影响诱导剂的作用。在上述剂量下,基础ALDH活性被DS(30%)和CC(70%)抑制,但不受PB或SKF 525A影响。当将各种测试的效应物给予已用MC(20 mg/kg,腹腔注射,每日×6)处理的动物时,结果略有不同。在这种情况下,DS不影响已诱导的ALDH活性。相反,CC仍然是一种有效的抑制剂。出乎意料的是,用SKF 525A进行后处理进一步增强了MC引起的初始诱导作用。我们的研究结果表明,影响微粒体药物代谢的物质可干扰MC诱导ALDH的过程。PB预处理的累加结果可能是由于MC活性代谢物的积累增加。(摘要截短至250字)